Although, in the past years, an increasing use of ketamine in Traumatic Brain injury (TBI)
has been reported as an adjunct to other sedatives, there is no evidence from randomized
clinical trial to support this practice.
The BIKe (Brain Injury and Ketamine) study is a double-blind placebo controlled randomized
multicenter clinical trial to examine the safety and feasibility of using ketamine as an
adjunct to a standard sedative strategy in TBI patients.
Phase:
Phase 4
Details
Lead Sponsor:
Geert Meyfroidt, MD, PhD
Collaborators:
AZ Delta AZ Sint-Jan AV AZ Turnhout Centre Hospitalier Régional de la Citadelle University of Liege